Work

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

Year: 2015

Type: article

Study design: Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(15)60721-8

Author: †

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Bill and Melinda Gates Foundation, GlaxoSmithKline, PATH, Wellcome Trust, University of Oxford, Medicines for Malaria Venture, Université de Genève, Centers for Disease Control and Prevention, GlaxoSmithKline Biologicals

Award: Core Support for the East African Major Overseas Programme

OpenAlex ID: W4254848468

FWCI: 142.2

Cites: 17

Cited by: 1,635

Related to: 10